Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Return on Assets: 2020-2024

Historic Return on Assets for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2024 value amounting to -0.07%.

  • Eton Pharmaceuticals' Return on Assets rose 10.00% to -0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.06%, marking a year-over-year increase of 10.00%. This contributed to the annual value of -0.07% for FY2024, which is 4.00% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Return on Assets of -0.07% as of FY2024, which was down 114.97% from -0.03% recorded in FY2023.
  • Eton Pharmaceuticals' Return on Assets' 5-year high stood at -0.03% during FY2023, with a 5-year trough of -1.29% in FY2020.
  • Moreover, its 3-year median value for Return on Assets was -0.07% (2024), whereas its average is -0.15%.
  • In the last 5 years, Eton Pharmaceuticals' Return on Assets soared by 122bps in 2021 and then decreased by 27bps in 2022.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Return on Assets stood at -1.29% in 2020, then spiked by 122bps to -0.07% in 2021, then dropped by 27bps to -0.34% in 2022, then skyrocketed by 31bps to -0.03% in 2023, then fell by 4bps to -0.07% in 2024.